Amarin reported $294.66M in Ordinary Share Capital for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ordinary Share Capital Change
DBV Technologies DBVT:US 10.71M 4.17M
Aerie Pharmaceuticals AERI:US $ 0.05M 0M
Alnylam Pharmaceuticals ALNY:US $ 1.21M 0M
Amarin AMRN:US $ 294.66M 0.3M
AstraZeneca AZN:LN 387M 0M
Epizyme EPZM:US $ 0.02M 0M
Esperion Therapeutics ESPR:US $ 65K 4K
GlaxoSmithKline GSK:LN 134700M 0M
Halozyme Therapeutics HALO:US $ 0.14M 0M
Heron Therapeutics HRTX:US $ 1.02M 0M
Intercept Pharmaceuticals ICPT:US $ 0.03M 0M
IONIS PHARMACEUT IONS:US $ 0.14M 0M
JAZZ PHA JAZZ:US $ 0.06M 0M
Nektar Therapeutics NKTR:US $ 0.02M 0M
Neurocrine Biosciences NBIX:US $ 0.1M 0M
Novartis NOVN:VX SF 890M 11M
Teva Pharmaceutical Industries TEVA:US $ 57M 0M